BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25595898)

  • 1. The T-box transcription factor, TBX3, is a key substrate of AKT3 in melanomagenesis.
    Peres J; Mowla S; Prince S
    Oncotarget; 2015 Jan; 6(3):1821-33. PubMed ID: 25595898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tbx3 represses E-cadherin expression and enhances melanoma invasiveness.
    Rodriguez M; Aladowicz E; Lanfrancone L; Goding CR
    Cancer Res; 2008 Oct; 68(19):7872-81. PubMed ID: 18829543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TBX3 Promotes Melanoma Migration by Transcriptional Activation of ID1, which Prevents Activation of E-Cadherin by MITF.
    Peres J; Damerell V; Chauhan J; Popovic A; Desprez PY; Galibert MD; Goding CR; Prince S
    J Invest Dermatol; 2021 Sep; 141(9):2250-2260.e2. PubMed ID: 33744299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tumour suppressor, miR-137, inhibits malignant melanoma migration by targetting the TBX3 transcription factor.
    Peres J; Kwesi-Maliepaard EM; Rambow F; Larue L; Prince S
    Cancer Lett; 2017 Oct; 405():111-119. PubMed ID: 28757416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic B-RAF(V600E) signaling induces the T-Box3 transcriptional repressor to repress E-cadherin and enhance melanoma cell invasion.
    Boyd SC; Mijatov B; Pupo GM; Tran SL; Gowrishankar K; Shaw HM; Goding CR; Scolyer RA; Mann GJ; Kefford RF; Rizos H; Becker TM
    J Invest Dermatol; 2013 May; 133(5):1269-77. PubMed ID: 23190890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of T-cadherin (CDH-13) regulates AKT signaling and desensitizes cells to apoptosis in melanoma.
    Bosserhoff AK; Ellmann L; Quast AS; Eberle J; Boyle GM; Kuphal S
    Mol Carcinog; 2014 Aug; 53(8):635-47. PubMed ID: 23625515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COL1A2 is a TBX3 target that mediates its impact on fibrosarcoma and chondrosarcoma cell migration.
    Omar R; Cooper A; Maranyane HM; Zerbini L; Prince S
    Cancer Lett; 2019 Sep; 459():227-239. PubMed ID: 31202624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UV-mediated regulation of the anti-senescence factor Tbx2.
    Abrahams A; Mowla S; Parker MI; Goding CR; Prince S
    J Biol Chem; 2008 Jan; 283(4):2223-30. PubMed ID: 18025091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The T-box transcription factor, TBX3, is sufficient to promote melanoma formation and invasion.
    Peres J; Prince S
    Mol Cancer; 2013 Oct; 12(1):117. PubMed ID: 24098938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PRAS40 deregulates apoptosis in malignant melanoma.
    Madhunapantula SV; Sharma A; Robertson GP
    Cancer Res; 2007 Apr; 67(8):3626-36. PubMed ID: 17440074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new PKCα/β/TBX3/E-cadherin pathway is involved in PLCε-regulated invasion and migration in human bladder cancer cells.
    Du HF; Ou LP; Yang X; Song XD; Fan YR; Tan B; Luo CL; Wu XH
    Cell Signal; 2014 Mar; 26(3):580-93. PubMed ID: 24316392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells.
    Ye M; Hu D; Tu L; Zhou X; Lu F; Wen B; Wu W; Lin Y; Zhou Z; Qu J
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):497-504. PubMed ID: 18234991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tbx3 fosters pancreatic cancer growth by increased angiogenesis and activin/nodal-dependent induction of stemness.
    Perkhofer L; Walter K; Costa IG; Carrasco MC; Eiseler T; Hafner S; Genze F; Zenke M; Bergmann W; Illing A; Hohwieler M; Köhntop R; Lin Q; Holzmann KH; Seufferlein T; Wagner M; Liebau S; Hermann PC; Kleger A; Müller M
    Stem Cell Res; 2016 Sep; 17(2):367-378. PubMed ID: 27632063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basal transcription of the human TBX3 gene, a key developmental regulator which is overexpressed in several cancers, requires functional NF-Y and Sp1 sites.
    Smith J; Mowla S; Prince S
    Gene; 2011 Oct; 486(1-2):41-6. PubMed ID: 21784138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melanoblasts in culture as an in vitro system to determine molecular changes in melanoma.
    Bosserhoff AK; Ellmann L; Kuphal S
    Exp Dermatol; 2011 May; 20(5):435-40. PubMed ID: 21496114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TBX3 and its splice variant TBX3 + exon 2a are functionally similar.
    Hoogaars WM; Barnett P; Rodriguez M; Clout DE; Moorman AF; Goding CR; Christoffels VM
    Pigment Cell Melanoma Res; 2008 Jun; 21(3):379-87. PubMed ID: 18444963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cadherin switch from E- to N-cadherin in melanoma progression is regulated by the PI3K/PTEN pathway through Twist and Snail.
    Hao L; Ha JR; Kuzel P; Garcia E; Persad S
    Br J Dermatol; 2012 Jun; 166(6):1184-97. PubMed ID: 22332917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cadherin-7 interacts with melanoma inhibitory activity protein and negatively modulates melanoma cell migration.
    Winklmeier A; Contreras-Shannon V; Arndt S; Melle C; Bosserhoff AK
    Cancer Sci; 2009 Feb; 100(2):261-8. PubMed ID: 19200257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-cadherin regulates mammary tumor cell migration through Akt3 suppression.
    Chung S; Yao J; Suyama K; Bajaj S; Qian X; Loudig OD; Eugenin EA; Phillips GR; Hazan RB
    Oncogene; 2013 Jan; 32(4):422-30. PubMed ID: 22410780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PMA-induced up-regulation of TBX3 is mediated by AP-1 and contributes to breast cancer cell migration.
    Mowla S; Pinnock R; Leaner VD; Goding CR; Prince S
    Biochem J; 2011 Jan; 433(1):145-53. PubMed ID: 20942798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.